148 related articles for article (PubMed ID: 29569387)
1. A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.
Wang Y; Yang ZY; Chen YH; Li F; Shen H; Yu Y; Huang HY; Shen ZY
J Cell Mol Med; 2018 Jun; 22(6):3005-3015. PubMed ID: 29569387
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.
Tan X; Wang Y; Han Y; Chang W; Su T; Hou J; Xu D; Yu Y; Ma W; Thompson TC; Cao G
Br J Cancer; 2013 Dec; 109(12):3105-15. PubMed ID: 24157827
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
4. miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W.
Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
Tumour Biol; 2015 Sep; 36(9):6875-82. PubMed ID: 25846734
[TBL] [Abstract][Full Text] [Related]
5. Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation.
Liu X; Campbell MR; Pittman GS; Faulkner EC; Watson MA; Bell DA
Cancer Res; 2005 Jan; 65(1):99-104. PubMed ID: 15665284
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
Wang X; Li H; Cui L; Feng J; Fan Q
Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
[TBL] [Abstract][Full Text] [Related]
7. Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.
Liao YC; Liu PY; Lin HF; Lin WY; Liao JK; Juo SH
J Mol Cell Cardiol; 2015 Feb; 79():180-6. PubMed ID: 25481646
[TBL] [Abstract][Full Text] [Related]
8. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Wang LN; Zhu XQ; Song XS; Xu Y
J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
[TBL] [Abstract][Full Text] [Related]
12. [Polymorphism at the miR-502 binding site in the 3' untranslated region of SET8 gene is associated with the risk of clear cell renal cell carcinoma].
Xu JS; Bai YL; Zhang JX; Cui LW; Zhang HR; Zhang SL
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):476-80. PubMed ID: 27346408
[TBL] [Abstract][Full Text] [Related]
13. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
[TBL] [Abstract][Full Text] [Related]
14. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
[TBL] [Abstract][Full Text] [Related]
15. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C; Uemura M; Tomiyama E; Matsushita M; Koh Y; Nakano K; Hayashi Y; Ishizuya Y; Jingushi K; Kato T; Hatano K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Tsujikawa K; Nonomura N
Cancer Sci; 2020 Apr; 111(4):1146-1155. PubMed ID: 31975504
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1.
Yu KD; Fan L; Di GH; Yuan WT; Zheng Y; Huang W; Chen AX; Yang C; Wu J; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2010 Jun; 121(2):485-96. PubMed ID: 19856098
[TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]